Log in with Facebook 
The Federal Food, Drug, and Cosmetic Act (FD&C) has enacted a law under Section 745A(a) that the regulatory submissions including investigational new drug applications (INDs), new drug applications (NDAs), abbreviated new drug applications (ANDAs) and biologics license applications (BLAs) should be submitted in electronic format to Food and Drug Administration (FDA). Read More
